Terms: = Prostate cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Diagnosis
18 results:
1. Clinical stage and grade migration of localized prostate cancer at diagnosis during the past decade.
Beatrici E; Filipas DK; Stone BV; Labban M; Qian Z; Lipsitz SR; Lughezzani G; Buffi NM; Cole AP; Trinh QD
Urol Oncol; 2023 Dec; 41(12):483.e11-483.e19. PubMed ID: 37852818
[TBL] [Abstract] [Full Text] [Related]
2. Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.
Kim DG; Yoo JW; Koo KC; Chung BH; Lee KS
BMC Urol; 2022 Oct; 22(1):164. PubMed ID: 36309672
[TBL] [Abstract] [Full Text] [Related]
3. Intermediate-term oncological outcomes after a negative endorectal coil multiparametric MRI of the prostate in patients without biopsy proven prostate cancer.
Kamal O; Comerford J; Foster BR; Young DJ; Amling C; Coakley FV
Clin Imaging; 2022 Dec; 92():112-116. PubMed ID: 36306588
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of Apparent Diffusion Coefficient Value and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters of prostate cancer Patients after diagnosis and Treatment with Magnetic Resonance Imaging.
Gu P
Comput Math Methods Med; 2022; 2022():3111054. PubMed ID: 35785146
[TBL] [Abstract] [Full Text] [Related]
5. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
6. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
[TBL] [Abstract] [Full Text] [Related]
7. cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract] [Full Text] [Related]
8. Anisotropic 3D Multi-Stream CNN for Accurate prostate Segmentation from Multi-Planar MRI.
Meyer A; Chlebus G; Rak M; Schindele D; Schostak M; van Ginneken B; Schenk A; Meine H; Hahn HK; Schreiber A; Hansen C
Comput Methods Programs Biomed; 2021 Mar; 200():105821. PubMed ID: 33218704
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients.
Harraz AM; Atia N; Ismail A; Shady A; Farg H; Gabr H; Fouda M; Abol-Enein H; Abdel-Aziz AF
Int Urol Nephrol; 2020 Aug; 52(8):1483-1490. PubMed ID: 32166568
[TBL] [Abstract] [Full Text] [Related]
10. Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.
Białkowska K; Marciniak W; Muszyńska M; Baszuk P; Gupta S; Jaworska-Bieniek K; Sukiennicki G; Durda K; Gromowski T; Prajzendanc K; Cybulski C; Huzarski T; Gronwald J; Dębniak T; Scott RJ; Lubiński J; Jakubowska A
PLoS One; 2018; 13(7):e0201065. PubMed ID: 30036379
[TBL] [Abstract] [Full Text] [Related]
11. Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels.
Haldrup C; Lynnerup AS; Storebjerg TM; Vang S; Wild P; Visakorpi T; Arsov C; Schulz WA; Lindberg J; Grönberg H; Egevad L; Borre M; Ørntoft TF; Høyer S; Sørensen KD
Mol Oncol; 2016 Jun; 10(6):825-37. PubMed ID: 26905753
[TBL] [Abstract] [Full Text] [Related]
12. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract] [Full Text] [Related]
13. [Comparative analysis of gene expression in normal and cancer human prostate cell lines].
Rosenberg IeE; Herashchenko HV; Kashuba VI
Ukr Biochem J; 2014; 86(2):119-28. PubMed ID: 24868918
[TBL] [Abstract] [Full Text] [Related]
14. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract] [Full Text] [Related]
15. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
[TBL] [Abstract] [Full Text] [Related]
16. Marital status and survival in patients with cancer.
Aizer AA; Chen MH; McCarthy EP; Mendu ML; Koo S; Wilhite TJ; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Hu JC; Nguyen PL
J Clin Oncol; 2013 Nov; 31(31):3869-76. PubMed ID: 24062405
[TBL] [Abstract] [Full Text] [Related]
17. [Assessment of the PCA3 test for prostate cancer diagnosis: a systematic review and meta-analysis].
Ruiz-Aragón J; Márquez-Peláez S
Actas Urol Esp; 2010 Apr; 34(4):346-55. PubMed ID: 20470697
[TBL] [Abstract] [Full Text] [Related]
18. The agreement among urological experts on the diagnostic management of patients with common urological problems.
Hansen MV; Zdanowski A
Br J Urol; 1997 Nov; 80(5):787-92. PubMed ID: 9393304
[TBL] [Abstract] [Full Text] [Related]
